A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
Traynor AM; Lee JW; Bayer GK; Tate JM; Thomas SP; Mazurczak M; Graham DL; Kolesar JM; Schiller JH; Investigational New Drugs, 2010, vol. 28, issue 1, p 91, ISSN 15730646. ISBN 15730646.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef